.png){kind=icon}
返回
Smart Nanoparticles for Chemo-Based Combinational Therapy
.png){kind=icon}
OA
AI
DOI：10.3390/pharmaceutics13060853.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Cancer is a heterogeneous and complex disease. Traditional cancer therapy is associated with low therapeutic index, acquired resistance, and various adverse effects. With the increasing understanding of cancer biology and technology advancements, more strategies have been exploited to optimize the therapeutic outcomes. The rapid development and application of nanomedicine have motivated this progress. Combinational regimen, for instance, has become an indispensable approach for effective cancer treatment, including the combination of chemotherapeutic agents, chemo-energy, chemo-gene, chemo-small molecules, and chemo-immunology. Additionally, smart nanoplatforms that respond to external stimuli (such as light, temperature, ultrasound, and magnetic field), and/or to internal stimuli (such as changes in pH, enzymes, hypoxia, and redox) have been extensively investigated to improve precision therapy. Smart nanoplatforms for combinational therapy have demonstrated the potential to be the next generation cancer treatment regimen. This review aims to highlight the recent advances in smart combinational therapy.
Keyword:
stimuli-responsive
multi-functional
smart nanoparticles
combinational
chemotherapy
cancer
treatment
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.5
论文数:
1.5W
被引数:
6.2W
机构
引用论文
Intelligent Albumin-MnO2 Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy智能Albumin-MnO2纳米颗粒作为pH-/H2O2-Responsive可解离的纳米载体调节肿瘤缺氧，用于有效的联合治疗.png)
ADVANCED MATERIALS
ADVANCED MATERIALSIF26.8
PREAI
分享收藏Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment二元协同前药纳米粒通过协同调节免疫肿瘤微环境改善免疫治疗ADVANCED MATERIALS
ADVANCED MATERIALSIF26.8
PREAI
分享收藏Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer阿特珠单抗和Nab-紫杉醇治疗晚期三阴性乳腺癌OAAI
OAAI分享收藏Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trialLANCETOAAI
LANCETIF88.5
OAAI分享收藏ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy用于触发药物递送和有效癌症治疗的ROS响应性聚前药纳米颗粒ADVANCED MATERIALSOAAI
ADVANCED MATERIALSIF26.8
OAAI分享收藏
查看更多内容